251 related articles for article (PubMed ID: 20043205)
1. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
[TBL] [Abstract][Full Text] [Related]
2. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis.
Ma Y; Tang RK; Yang X; Peng GG; Liu Y; Wang XM; Wu BH; Yu JM
Hum Immunol; 2011 Aug; 72(8):641-51. PubMed ID: 21536090
[TBL] [Abstract][Full Text] [Related]
5. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.
Yu KD; Chen AX; Qiu LX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
[TBL] [Abstract][Full Text] [Related]
7. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
8. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
9. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
[TBL] [Abstract][Full Text] [Related]
10. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk.
Yu KD; Chen AX; Yang C; Fan L; Huang AJ; Shao ZM
Breast Cancer Res Treat; 2012 Jan; 131(1):27-31. PubMed ID: 20737205
[TBL] [Abstract][Full Text] [Related]
11. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
[TBL] [Abstract][Full Text] [Related]
12. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
14. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
[TBL] [Abstract][Full Text] [Related]
15. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Xue K; Zhang J; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
[TBL] [Abstract][Full Text] [Related]
16. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
Wang Z; Cui D; Lu W
Breast Cancer Res Treat; 2010 Sep; 123(2):557-61. PubMed ID: 20143155
[TBL] [Abstract][Full Text] [Related]
17. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
18. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
Yao L; Fang F; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
[TBL] [Abstract][Full Text] [Related]
19. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
20. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
